DK3395357T3 - Sammensætning til kontrolleret ovariestimulering - Google Patents

Sammensætning til kontrolleret ovariestimulering Download PDF

Info

Publication number
DK3395357T3
DK3395357T3 DK18167552.1T DK18167552T DK3395357T3 DK 3395357 T3 DK3395357 T3 DK 3395357T3 DK 18167552 T DK18167552 T DK 18167552T DK 3395357 T3 DK3395357 T3 DK 3395357T3
Authority
DK
Denmark
Prior art keywords
ovari
stimulation
composition
controlled
ovari stimulation
Prior art date
Application number
DK18167552.1T
Other languages
English (en)
Inventor
Joan-Carles Arce
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46785372&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3395357(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Bv filed Critical Ferring Bv
Application granted granted Critical
Publication of DK3395357T3 publication Critical patent/DK3395357T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/24Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK18167552.1T 2011-08-08 2012-08-08 Sammensætning til kontrolleret ovariestimulering DK3395357T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11176803 2011-08-08
EP14184409.2A EP2821080B1 (en) 2011-08-08 2012-08-08 Composition for controlled ovarian stimulation

Publications (1)

Publication Number Publication Date
DK3395357T3 true DK3395357T3 (da) 2019-08-19

Family

ID=46785372

Family Applications (8)

Application Number Title Priority Date Filing Date
DK18167552.1T DK3395357T3 (da) 2011-08-08 2012-08-08 Sammensætning til kontrolleret ovariestimulering
DK20186935.1T DK3756681T3 (da) 2011-08-08 2012-08-08 Sammensætning til kontrolleret ovariestimulering
DK19213649.7T DK3646881T3 (da) 2011-08-08 2012-08-08 Sammensætning til kontrolleret ovariestimulering
DK12753675.3T DK2741763T3 (da) 2011-08-08 2012-08-08 Sammensætning til kontrolleret ovariestimulering.
DK19164277.6T DK3566712T3 (da) 2011-08-08 2012-08-08 Sammensætning til kontrolleret ovariestimulering
DK17154031.3T DK3195875T3 (da) 2011-08-08 2012-08-08 Sammensætning til kontrolleret ovariestimulering
DK14184409.2T DK2821080T3 (da) 2011-08-08 2012-08-08 Sammensætning til kontrolleret ovariestimulering.
DK21207717.6T DK4005588T3 (da) 2011-08-08 2012-08-08 Sammensætning til kontrolleret ovariestimulering

Family Applications After (7)

Application Number Title Priority Date Filing Date
DK20186935.1T DK3756681T3 (da) 2011-08-08 2012-08-08 Sammensætning til kontrolleret ovariestimulering
DK19213649.7T DK3646881T3 (da) 2011-08-08 2012-08-08 Sammensætning til kontrolleret ovariestimulering
DK12753675.3T DK2741763T3 (da) 2011-08-08 2012-08-08 Sammensætning til kontrolleret ovariestimulering.
DK19164277.6T DK3566712T3 (da) 2011-08-08 2012-08-08 Sammensætning til kontrolleret ovariestimulering
DK17154031.3T DK3195875T3 (da) 2011-08-08 2012-08-08 Sammensætning til kontrolleret ovariestimulering
DK14184409.2T DK2821080T3 (da) 2011-08-08 2012-08-08 Sammensætning til kontrolleret ovariestimulering.
DK21207717.6T DK4005588T3 (da) 2011-08-08 2012-08-08 Sammensætning til kontrolleret ovariestimulering

Country Status (31)

Country Link
US (4) US9694052B2 (da)
EP (9) EP3566712B1 (da)
JP (5) JP6161609B2 (da)
KR (7) KR102111514B1 (da)
CN (2) CN103732243A (da)
AR (1) AR087476A1 (da)
AU (3) AU2012293647B2 (da)
BR (2) BR112014002884A2 (da)
CA (1) CA2844282A1 (da)
CY (1) CY1117214T1 (da)
DK (8) DK3395357T3 (da)
ES (7) ES2871405T3 (da)
FI (2) FI3756681T3 (da)
HK (2) HK1204923A1 (da)
HR (7) HRP20230607T1 (da)
HU (7) HUE053716T2 (da)
IL (2) IL300380A (da)
JO (1) JO3092B1 (da)
LT (7) LT3395357T (da)
MX (2) MX348981B (da)
PL (7) PL2741763T3 (da)
PT (6) PT3646881T (da)
RS (7) RS54561B1 (da)
RU (2) RU2739037C3 (da)
SA (1) SA112330762B1 (da)
SI (7) SI2741763T1 (da)
SM (1) SMT201600038B (da)
TR (2) TR201900071T4 (da)
TW (2) TWI657822B (da)
WO (1) WO2013020996A1 (da)
ZA (2) ZA201400952B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI488640B (zh) 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
TWI532495B (zh) * 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
JO3092B1 (ar) 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض
JP2018500934A (ja) * 2014-12-22 2018-01-18 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft Cmp依存性シアリダーゼ活性
WO2016166288A1 (en) 2015-04-17 2016-10-20 Ferring B.V. Composition for treatment of infertility
AU2016282916B2 (en) 2015-06-26 2022-01-20 Ferring B.V. Methods of purification and/or viral inactivation
JP7255050B2 (ja) * 2015-09-17 2023-04-11 グアンジョウ・カントン・バイオロジクス・カンパニー・リミテッド 安定性の増大した哺乳類卵胞刺激ホルモン組成物
EP3518952A1 (en) * 2016-09-30 2019-08-07 Myovant Sciences GmbH Methods of treating female infertility
CN111050787A (zh) * 2017-09-01 2020-04-21 辉凌公司 用于受控的卵巢刺激的组合物
CN112088011A (zh) * 2018-04-30 2020-12-15 辉凌公司 用于受控的卵巢刺激的组合物
TW202027780A (zh) 2018-10-17 2020-08-01 荷蘭商菲林公司 用於控制性卵巢刺激之組成物及方法
US11576920B2 (en) 2019-03-18 2023-02-14 The Menopause Method, Inc. Composition and method to aid in hormone replacement therapy
CN110841060A (zh) * 2019-11-21 2020-02-28 上海交通大学 Choriogonadotropin alfa在治疗***中的应用
TW202237173A (zh) 2020-12-09 2022-10-01 荷蘭商菲林公司 用於受控的卵巢刺激之組成物及方法
WO2023186331A1 (en) 2022-04-01 2023-10-05 Ferring B.V. Mixed protocol for treatment of infertility
WO2023227761A1 (en) 2022-05-26 2023-11-30 Ferring B.V. Compositions and methods for treatment of infertility in males
WO2024008971A1 (en) 2022-07-08 2024-01-11 Ferring B.V. Compositions and methods for intrauterine insemination (iui)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW518235B (en) 1997-01-15 2003-01-21 Akzo Nobel Nv A gonadotropin-containing pharmaceutical composition with improved stability on prolong storage
EP1074265A1 (en) * 1999-08-03 2001-02-07 Erasmus Universiteit Rotterdam Use of AMH and/or AMH agonists and/or AMH antagonists for long-term control of female fertility
US20050085412A1 (en) 2001-10-22 2005-04-21 Applied Research Systems Ars Holding N.V. Gonadotrophins for folliculogenesis
US20040248784A1 (en) * 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
US8501719B2 (en) * 2005-11-08 2013-08-06 American Infertility Of New York Androgen treatment in females
TWI488640B (zh) 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
TWI532495B (zh) * 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
EP2417982A1 (en) 2010-07-30 2012-02-15 Ferring B.V. Stabilization of gonadotropins
WO2012016576A1 (en) 2010-08-04 2012-02-09 Glycotope Gmbh Improved recombinant human follicle-stimulating hormone
HUE025514T2 (en) * 2010-09-29 2016-02-29 Ferring Bv Preparation for use in treating infertility
JO3092B1 (ar) 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض

Also Published As

Publication number Publication date
SI2741763T1 (sl) 2016-02-29
EP2741763B1 (en) 2015-11-18
RS59107B1 (sr) 2019-09-30
HUE027674T2 (en) 2016-11-28
AR087476A1 (es) 2014-03-26
KR20230024442A (ko) 2023-02-20
DK4005588T3 (da) 2024-04-29
EP2821080A1 (en) 2015-01-07
HUE044610T2 (hu) 2019-11-28
EP3195875B1 (en) 2018-07-25
FI3756681T3 (fi) 2023-07-28
EP3395357A1 (en) 2018-10-31
LT3195875T (lt) 2018-11-12
AU2016273925A1 (en) 2017-01-12
PL3756681T3 (pl) 2023-08-21
PT3395357T (pt) 2019-08-27
US20140329748A1 (en) 2014-11-06
EP3195875A1 (en) 2017-07-26
HRP20230607T1 (hr) 2023-09-29
HUE040058T2 (hu) 2019-02-28
HRP20210277T1 (hr) 2021-04-02
WO2013020996A1 (en) 2013-02-14
HUE053716T2 (hu) 2021-07-28
KR102014469B1 (ko) 2019-08-26
ES2704878T3 (es) 2019-03-20
JP2017141253A (ja) 2017-08-17
RU2017106756A3 (da) 2020-07-09
AU2018203222A1 (en) 2018-05-24
ZA201506382B (en) 2017-01-25
DK3756681T3 (da) 2023-07-31
CY1117214T1 (el) 2017-04-05
IL300380A (en) 2023-04-01
ES2884947T3 (es) 2021-12-13
RU2613324C2 (ru) 2017-03-15
ES2871405T3 (es) 2021-10-28
EP3646881A1 (en) 2020-05-06
JP2019077693A (ja) 2019-05-23
JP2014522871A (ja) 2014-09-08
SI3566712T1 (sl) 2021-04-30
PT2821080T (pt) 2018-12-17
EP3566712A1 (en) 2019-11-13
KR20210143934A (ko) 2021-11-29
EP3566712B1 (en) 2021-01-27
RU2739037C2 (ru) 2020-12-21
EP4005588A1 (en) 2022-06-01
PT4005588T (pt) 2024-04-24
US11291708B2 (en) 2022-04-05
AU2012293647A1 (en) 2014-02-27
HUE041769T2 (hu) 2019-05-28
HRP20190023T1 (hr) 2019-02-22
JP2023134561A (ja) 2023-09-27
AU2018203222B2 (en) 2020-03-12
US20200345814A1 (en) 2020-11-05
RU2613324C3 (ru) 2021-06-09
PL3566712T3 (pl) 2021-07-12
HK1204923A1 (en) 2015-12-11
PL2741763T3 (pl) 2016-07-29
LT2821080T (lt) 2019-01-10
MX2020010991A (es) 2020-11-09
US20220370567A1 (en) 2022-11-24
ES2742163T3 (es) 2020-02-13
RS61843B1 (sr) 2021-06-30
SMT201600038B (it) 2016-02-25
RS64328B1 (sr) 2023-08-31
MX348981B (es) 2017-07-06
SI2821080T1 (sl) 2019-01-31
LT3646881T (lt) 2021-05-25
IL230696A0 (en) 2014-03-31
KR20140054191A (ko) 2014-05-08
KR20190140098A (ko) 2019-12-18
KR102353144B1 (ko) 2022-01-18
EP4005588B1 (en) 2024-02-07
LT3756681T (lt) 2023-07-25
SI3756681T1 (sl) 2023-08-31
ES2562648T3 (es) 2016-03-07
RU2017106756A (ru) 2019-01-23
NZ620369A (en) 2015-12-24
SI3646881T1 (sl) 2021-08-31
KR20190100449A (ko) 2019-08-28
RS54561B1 (en) 2016-06-30
AU2012293647B2 (en) 2016-10-06
HRP20160145T1 (hr) 2016-04-08
DK3566712T3 (da) 2021-04-19
EP3756681A1 (en) 2020-12-30
MX2014001489A (es) 2014-04-25
US10624953B2 (en) 2020-04-21
IL230696B2 (en) 2023-07-01
SA112330762B1 (ar) 2015-10-08
HUE062640T2 (hu) 2023-11-28
RU2739037C3 (ru) 2021-09-08
EP3646881B1 (en) 2021-04-28
RS57897B1 (sr) 2019-01-31
AU2016273925B2 (en) 2018-03-15
EP3756681B1 (en) 2023-05-03
EP4306174A3 (en) 2024-04-10
RS61672B1 (sr) 2021-04-29
PT3756681T (pt) 2023-07-25
KR102111514B1 (ko) 2020-05-18
JP6718951B2 (ja) 2020-07-08
BR112014002884A2 (pt) 2017-02-21
LT3395357T (lt) 2019-08-26
TWI657822B (zh) 2019-05-01
JP6161609B2 (ja) 2017-07-12
DK2741763T3 (da) 2016-02-15
ES2950911T3 (es) 2023-10-16
PL3646881T3 (pl) 2021-11-02
KR20210099162A (ko) 2021-08-11
JP6500050B2 (ja) 2019-04-10
EP3395357B1 (en) 2019-05-15
LT3566712T (lt) 2021-03-10
KR102499969B1 (ko) 2023-02-14
PL2821080T3 (pl) 2019-04-30
TR201911269T4 (tr) 2019-08-21
HK1198005A1 (zh) 2015-03-06
LT4005588T (lt) 2024-03-25
SI3195875T1 (sl) 2018-11-30
TR201900071T4 (tr) 2019-01-21
PL3395357T3 (pl) 2019-11-29
KR20200121918A (ko) 2020-10-26
EP2741763A1 (en) 2014-06-18
EP2821080B1 (en) 2018-10-10
CN107281470A (zh) 2017-10-24
DK3646881T3 (da) 2021-07-26
EP4306174A2 (en) 2024-01-17
US9694052B2 (en) 2017-07-04
PT3646881T (pt) 2021-06-02
TW201309322A (zh) 2013-03-01
CA2844282A1 (en) 2013-02-14
ES2692774T3 (es) 2018-12-05
PT3195875T (pt) 2018-10-31
PL3195875T3 (pl) 2019-01-31
TW201716082A (zh) 2017-05-16
DK3195875T3 (da) 2018-11-12
JO3092B1 (ar) 2017-03-15
DK2821080T3 (da) 2019-01-28
BR122020001644B1 (pt) 2022-08-02
ZA201400952B (en) 2022-03-30
CN103732243A (zh) 2014-04-16
JP7309660B2 (ja) 2023-07-18
SI3395357T1 (sl) 2019-09-30
RU2014102924A (ru) 2015-09-20
TWI555530B (zh) 2016-11-01
HRP20210722T1 (hr) 2021-06-11
JP2020147600A (ja) 2020-09-17
HRP20191437T1 (hr) 2019-11-15
RS58198B1 (sr) 2019-03-29
IL230696B1 (en) 2023-03-01
HRP20181639T1 (hr) 2018-12-14
US20180028620A1 (en) 2018-02-01
FI4005588T3 (fi) 2024-05-15
HUE054312T2 (hu) 2021-08-30

Similar Documents

Publication Publication Date Title
HRP20190023T1 (hr) Pripravak za kontroliranu stimulaciju jajnika
BR112013022112A2 (pt) composição
BR112013022102A2 (pt) composição
DK2686017T3 (da) Oftalmisk sammensætning
BR112014004395A2 (pt) composição
BR112013033808A2 (pt) composição
BR112014007030A2 (pt) composição
FI20115187A (fi) Ohjainväline
DK2726579T3 (da) Sammensætning
ES1073759Y (es) Maceta de germinacion controlada